{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:27:06Z","timestamp":1789079226304,"version":"build-2803163510"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Few studies on traumatic brain injury (TBI) have investigated the stability of blood serum biomarkers after long-term storage at low temperatures. In the current feasibility study we analyzed acute phase serum samples from patients with mild TBI as well as patients with moderate and severe TBI that were collected more than 10 years ago (<jats:italic>old samples<\/jats:italic>). We were particularly interested in mild TBI, because injury effects are more subtle in this category as compared to moderate-severe TBI. Therefore, the primary objective was to find out whether several biomarkers were still detectable for these patients. Additionally, we examined whether biomarker levels varied as a function of injury severity. For comparison, we also analyzed samples from an ongoing mTBI cohort (<jats:italic>new samples<\/jats:italic>) and healthy controls. Samples were treated with care and were not being subjected to freeze-thaw cycles. We measured concentrations of interleukins (IL6 and 10) and brain specific markers (total tau, UCH-L1, GFAP, and NF-L). No significant differences in biomarker concentrations were found between old and new mild TBI samples. For IL6, IL10, and UCH-L1 higher concentrations were found in moderate and severe TBI as compared to mild TBI. In conclusion, our study shows that long-term storage does not rule out the detection of meaningful biomarker concentrations in patients with TBI, although further research by other laboratories is warranted.<\/jats:p>","DOI":"10.3389\/fneur.2022.877050","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T07:26:46Z","timestamp":1652858806000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-Term Stability of Blood Serum Biomarkers in Traumatic Brain Injury: A Feasibility Study"],"prefix":"10.3389","volume":"13","author":[{"given":"Harm Jan","family":"van der Horn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Bijzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joukje","family":"van der Naalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12883-016-0723-z","article-title":"The addition of S100B to guidelines for management of mild head injury is potentially cost saving","volume":"16","author":"Calcagnile","year":"2016","journal-title":"BMC Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","article-title":"Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study","volume":"17","author":"Bazarian","year":"2018","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1780","DOI":"10.1212\/WNL.0000000000005518","article-title":"Neurofilament light and tau as blood biomarkers for sports-related concussion","volume":"90","author":"Shahim","year":"2018","journal-title":"Neurology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1089\/neu.2017.5449","article-title":"Testing a multivariate proteomic panel for traumatic brain injury biomarker discovery: a TRACK-TBI pilot study","volume":"36","author":"Huie","year":"2019","journal-title":"J Neurotrauma."},{"key":"B5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/jama.2013.169158","article-title":"Traumatic brain injury: an international knowledge-based approach","volume":"310","author":"Manley","year":"2013","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S1474-4422(17)30358-7","article-title":"The CENTER-TBI core study: the making-of","volume":"16","author":"Burton","year":"2017","journal-title":"Lancet Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1089\/neu.2018.6053","article-title":"Stability of blood biomarkers of traumatic brain injury","volume":"36","author":"Rezaii","year":"2019","journal-title":"J Neurotrauma."},{"key":"B8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1089\/neu.2009.1059","article-title":"Outcome prediction in mild traumatic brain injury: age and clinical variables are stronger predictors than CT abnormalities","volume":"27","author":"Jacobs","year":"2010","journal-title":"J Neurotrauma."},{"key":"B9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00001199-199309000-00010","article-title":"Definition of mild traumatic brain injury","volume":"8","author":"Kay","year":"1993","journal-title":"J Head Trauma Rehabil."},{"key":"B10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neubiorev.2021.11.036","article-title":"Blood-based biomarkers of inflammation in mild traumatic brain injury: a systematic review","volume":"132","author":"Visser","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40364-020-00256-7","article-title":"Prolonged elevation of serum neurofilament light after concussion in male Australian football players","volume":"9","author":"McDonald","year":"2021","journal-title":"Biomark Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jamaneurol.2016.0039","article-title":"Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury","volume":"73","author":"Papa","year":"2016","journal-title":"JAMA Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/ana.25874","article-title":"Remote blood biomarkers of longitudinal cognitive outcomes in a population study","volume":"88","author":"Rajan","year":"2020","journal-title":"Ann Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2172-10-52","article-title":"Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays","volume":"10","author":"De Jager","year":"2009","journal-title":"BMC Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.seizure.2018.07.010","article-title":"Serum GFAP level: a novel adjunctive diagnostic test in differentiate epileptic seizures from psychogenic attacks","volume":"61","author":"Simani","year":"2018","journal-title":"Seizure"},{"key":"B16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s13054-015-1081-8","article-title":"Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study","volume":"191","author":"Lei","year":"2015","journal-title":"Crit Care."},{"key":"B17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3389\/fneur.2017.00652","article-title":"A systematic review of the usefulness of glial fibrillary acidic protein for predicting acute intracranial lesions following head trauma","volume":"8","author":"Luoto","year":"2017","journal-title":"Front Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"ENEURO","DOI":"10.1523\/ENEURO.0294-16.2016","article-title":"Biomarkers of traumatic brain injury: temporal changes in body fluids","volume":"3","author":"Adrian","year":"2016","journal-title":"eNeuro."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1089\/neu.2021.0011","article-title":"The known unknowns: an overview of the state of blood-based protein biomarkers of mild traumatic brain injury","volume":"38","author":"Mcdonald","year":"2021","journal-title":"J Neurotrauma."},{"key":"B20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2217\/bmm-2020-0770","article-title":"Pre-analytical sample handling effects on blood cytokine levels: quality control of a COVID-19 biobank","volume":"15","author":"Verberk","year":"2021","journal-title":"Biomark Med."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.877050\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T07:26:49Z","timestamp":1652858809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.877050\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":20,"alternative-id":["10.3389\/fneur.2022.877050"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.877050","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"article-number":"877050"}}